Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells
Keywords: Curcumin; Osteopontin; Leukemic Stem Cell; Acute myeloid leukemia (AML); KG-1; U937 cells